|
|
|
|
| LEADER |
02605nam a22002775i 4500 |
| 001 |
000286603 |
| 005 |
20220120143455.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2006 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781597450119
|
| 024 |
7 |
|
|a 10.1385/1597450111
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Immunotherapy of Cancer /
|c edited by Mary L. Disis.
|
| 250 |
|
|
|a 1st ed. 2006.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2006.
|
| 300 |
|
|
|a XII, 516 p. 52 illus. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Cancer Drug Discovery and Development,
|
| 505 |
0 |
|
|a Discovery of Target Molecules for Cancer Immunotherapy by Genetic and Bioinformatic Approaches -- Current Strategies for the Identification of Immunogenic Epitopes of Tumor Antigens -- Current and Future Role of Natural-Killer Cells in Cancer Immunotherapy -- The Role of Immune Monitoring in Evaluating Cancer Immunotherapy -- Statistical Analysis of Immune Response Assays in Cancer Immunotherapy Trials -- DNA Vaccines for Cancer Immunotherapy -- Dendritic Cells -- Different Approaches to Dendritic Cell-Based Cancer Immunotherapy -- Anti-Idiotype Antibody Vaccines for the Immunotherapy of Cancer -- Autologous Tumor-Derived Heat Shock Protein Vaccine as a New Paradigm for Individualized Cancer Therapeutics -- Tumor-Reactive T-Cells for Adoptive Immunotherapy -- T-Cell Adoptive Immunotherapy of Cancer -- Retroviral-Mediated Gene Transfer for Engineering Tumor-Reactive T-Cells -- Harnessing the Potential of Graft-vs-Tumor -- Tumor-Induced Immune Suppression and Immune Escape -- The Tumor Microenvironment -- Manipulation of Lymphocyte Homeostasis for Enhancing Antitumor Immunity -- Fast-Lane Evolution in the Tumor Microenvironment -- Manipulating Immunological Checkpoints to Maximize Antitumor Immunity -- Interleukin-2 as Cancer Therapy -- Biological and Clinical Properties of the Type 1 Interferons -- Promising ?-Chain Cytokines for Cancer Immunotherapy -- The Therapeutic Use of Natural-Killer Cells in Hematological Malignancies -- Antibody Therapy for Solid Tumors -- Antibody Therapy for Non-Hodgkin’s Lymphoma -- Approaches to In Vivo Imaging of Cancer Immunotherapy -- Design Issues for Early-Stage Clinical Trials for Cancer Vaccines -- Monoclonal Antibody Therapy of Cancer.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
1 |
4 |
|a Cancer Research.
|
| 700 |
1 |
|
|a Disis, Mary L.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|